Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections
- PMID: 15356783
- PMCID: PMC7107828
- DOI: 10.1086/422996
Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections
Abstract
Background: Community-acquired pneumonia (CAP) in young children is most commonly associated with viral infections; however, the role of viruses in CAP of school-age children is still inconclusive.
Methods: Seventy-five school-age children hospitalized with CAP were prospectively evaluated for the presence of viral and bacterial pathogens. Nasopharyngeal washes were examined by polymerase chain reaction for viruses and atypical bacteria. Antibody assays to detect bacterial pathogens in acute-phase and convalescent-phase serum samples were also performed.
Results: A viral infection was identified in 65% of cases. Rhinovirus RNA was detected in 45% of patients; infection with another virus occurred in 31%. The most common bacterial pathogen was Mycoplasma pneumoniae, which was diagnosed in 35% of cases. Chlamydia pneumoniae DNA was not detected in any patient; results of serological tests were positive in only 2 patients (3%). Mixed infections were documented in 35% of patients, and the majority were a viral-bacterial combination.
Conclusions: The high prevalence of viral and mixed viral-bacterial infections supports the notion that the presence of a virus, acting either as a direct or an indirect pathogen, may be the rule rather than the exception in the development of CAP in school-age children requiring hospitalization.
Figures
Comment in
-
Rhinovirus and lower respiratory tract infection in adults.Clin Infect Dis. 2005 Apr 1;40(7):1068-9. doi: 10.1086/428359. Clin Infect Dis. 2005. PMID: 15825009 No abstract available.
References
-
- McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37. - PubMed
-
- Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471–7. - PubMed
-
- Harris JA, Kolokahtis A, Campbell M, Cassell G, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia. Pediatr Infect Dis J. 1998;17:865–71. - PubMed
-
- Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Mowgli Study Group. Clin Infect Dis. 2001;32:1281–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
